-
Clinical Research Alert: Phase 2 Study of NMD670 in Adults with Generalized Myasthenia Gravis (gMG)
Researchers at NMD Pharma A/S are working to better understand generalized myasthenia gravis (gMG) and study
-
Rare Disease Day: Momentum in Neuromuscular Diseases is Building, but Progress Depends on Sustained Investment
Every year on Rare Disease Day, communities around the world come together to shine a








